ReBio Pharma appoints Professor Mandeep Sagoo as CMO ahead of RBP-01 clinical push

The hire adds nearly 30 years of ophthalmology and ocular oncology experience as the company prepares to move its lead primary uveal melanoma program into the clinic.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.